CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response

Breast Cancer Res. 2005 Mar 29;7(6):E7. doi: 10.1186/bcr1326.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Female
  • Humans
  • Patient Selection
  • Prognosis
  • Reproducibility of Results
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Cytochrome P-450 CYP2D6